Organic & Biomolecular Chemistry
Paper
1-O-Benzyl-3-O-[(10RS)-10-methylheptadec-16-en-1-yl]-sn- (CH2)7CH(CH2)4, (CH2)13CH3), 1.51–1.59 (m,
4
H, 2×
glycerol (18b). Following the general procedure, 17b (3.43 g) CH2CH2O), 1.99–2.03 (m, 2 H, CH2CHvCH2), 3.41 (t, J =
gave 18b (3.3 g, 76%), slight yellow oil. [α]D22 −2.0 (c 0.04 g 6.6 Hz, 2 H, CH2O), 3.47–3.59 (m, 7 H, 3× CH2O, CHO), 4.54 (s,
mL−1, CHCl3); C28H48O3 requires C, 77.72; H, 11.18; found: C, 2 H, CH2C6H5), 4.89–4.99 (m, 2 H, CHvCH2), 5.75–5.85 (m,
77.39; H, 11.28%; 1H NMR (400 MHz; CDCl3) δ 0.82 (d, J = 6.6 Hz, 1 H, CHvCH2), 7.24–7.32 (m, 5 H, C6H5); 13C NMR (100 MHz;
3 H, CH3), 1.03–1.38 (m, 23 H, (CH2)7CH(CH2)4), 1.51–1.58 (m, CDCl3) δ 14.26, 19.87, 22.84, 26.28, 26.31, 27.07, 27.25, 29.15,
2 H, CH2CH2O), 2.00–2.06 (m, 2 H, CH2CHvCH2), 2.44 (d, J = 29.51–29.85, 30.19, 30.29, 32.07, 32.90, 33.96, 37.17, 37.25,
4.2 Hz, 1 H, –OH). 3.41–3.56 (m, 6 H, 3× CH2O), 3.94–4.00 (m, 70.49, 70.69, 70.89, 71.75, 73.45, 78.06, 114.07, 127.44, 127.53,
1 H, CHOH), 4.55 (s, 2 H, CH2C6H5), 4.89–5.00 (m, 2 H, 128.26, 138.48, 139.16; EI-MS m/z 656 (2%, M − H).
CHvCH2), 5.75–5.85 (m, 1 H, CHvCH2), 7.19–7.35 (m, 5 H,
1-O-Benzyl-3-O-[(10RS)-10-methylheptadec-16-en-1-yl]-2-O-
C6H5); 13C NMR (100 MHz; CDCl3) δ 19.77, 26.17, 26.97, 27.13, [(10RS)-methylhexadecyl]-sn-glycerol (19c). Following the
29.05, 29.55–29.71, 30.07, 32.81, 33.87, 37.08, 37.15, 69.61, general procedure, 18b (1.06 g) and 14a (2.43 g) gave 19c
71.47, 71.74, 71.83, 73.50, 114.07, 127.69, 128.40, 138.07, (1.10 g, 67%), colourless oil. [α]D22 −0.6 (c 0.1 g mL−1, CHCl3).
139.23; EI-MS m/z 432.2 (1%, M − H).
C45H82O3 requires C, 80.53; H, 12.32; found: C, 80.24; H,
12.40%; H NMR (400 MHz; CDCl3) δ 0.82 (d, J = 6.4 Hz, 6 H,
2× CHCH3), 0.87 (t, J = 6.8 Hz, 3 H, CH2CH3), 1.05–1.38 (m, 48
H, (CH2)7CH(CH2)4, (CH2)7CH(CH2)5CH3), 1.51–1.63 (m, 4 H,
1
General procedure for the synthesis of 1-O-benzyl-2,3-O,O-
dialkyl-sn-glycerols 19
Compounds 19a–c were synthesised according to the prepa- 2× CH2CH2O), 2.00–2.05 (m, 2 H, CH2CHvCH2), 3.41 (t, J =
ration of compounds 16a,b. KH (2.45 mmol, 0.3 mL 30% sus- 6.6 Hz, 2 H, CH2O), 3.44–3.61 (m, 7 H, 3× CH2O, CHO), 4.54 (s,
pension in mineral oil) was separated from the oil and 2 H, CH2C6H5), 4.89–5.00 (m, 2 H, CHvCH2), 5.75–5.85 (m,
suspended under argon in dry toluene (5 mL). A solution of 1 H, CHvCH2), 7.23–7.32 (m, 5 H, C6H5); 13C NMR (100 MHz;
18a or 18b (2.45 mmol) in dry toluene (15 mL) was added CDCl3) δ 14.29, 19.88, 19.90, 22.87, 26.30, 26.32, 27.08, 27.23,
slowly at r.t. and the mixture was stirred for 20 h at this temp- 27.26, 29.16, 29.66–29.85, 30.20, 30.30, 32.12, 32.91, 32.93,
erature. Afterwards, the bromide 14a and 1-bromohexadecane 33.97, 37.19, 37.26, 37.28, 70.47, 70.70, 70.88, 71.76, 73.45,
(7.6 mmol), respectively, dissolved in dry toluene (10 mL), were 78.06, 114.08, 127.45, 127.54, 128.27, 138.47, 139.17; EI-MS
added and the mixture was refluxed for 12 h. Subsequently, m/z 670 (5%, M − H).
the cooled reaction mixture was stirred vigorously with water
(30 mL). Then, brine (20 mL) was added and the organic layer
was separated. The water phase was extracted two times with
General procedure for the synthesis of 3,3′-O,O-(alkane-1,1′-
diyl)bis(2-O-alkyl-sn-glycerols) 20
toluene (20 mL) and the combined organic layers were dried The olefins 19a–c (1 mmol) were dissolved in dry CH2Cl2
over Na2SO4 and evaporated. The crude products were purified (30 mL) under an argon atmosphere. Then a solution of
by column chromatography using heptane–CHCl3 as the Grubbs first-generation catalyst {[RuCl2(vCHPh)(PCy3)2],
solvent and the gradient technique.
29 mol%, 0.18 g} in dry CH2Cl2 (25 mL) was added dropwise.
1-O-Benzyl-3-O-(heptadec-16-en-1-yl)-2-O-[(10RS)-10-methyl- The mixture was stirred for 24 h under reflux. Afterwards, the
hexadecyl]-sn-glycerol (19a). Following the general procedure, solvent was removed under reduced pressure and the crude
18a (1.02 g) and 14a (2.43 g) gave 19a (1.0 g, 62%), colourless residue was purified by column chromatography using a
oil. [α]D22 +0.4 (c 0.094 g mL−1, CHCl3); C44H80O3 requires C, heptane–CHCl3 gradient. The subsequently performed hydro-
80.42; H, 12.27; found: C, 80.29; H, 12.11%; 1H NMR genation of the double bonds and the removal of the benzyl
(400 MHz; CDCl3) δ 0.82 (d, J = 6.4 Hz, 3 H, CHCH3), 0.87 (t, J = blocking groups were realised in one step. Therefore, the
7.0 Hz, 3 H, CH2CH3), 1.05–1.38 (m, 49 H, (CH2)12, (CH2)7CH- olefins were dissolved in EtOH–EtOAc (50 mL, 1/1, v/v). After
(CH2)5), 1.51–1.64 (m, 4 H, 2× CH2CH2O), 1.99–2.05 (m, 2 H, the addition of Pd(OH)2 (33 mol%, 20% on carbon) the
CH2CHvCH2), 3.41 (t, J = 6.6 Hz, 2 H, CH2O), 3.44–3.64 (m, mixture was stirred under hydrogen (2 atm) at r.t. for 18 h. The
7 H, 3× CH2O, CHO). 4.55 (s, 2 H, CH2C6H5), 4.89–5.00 catalyst was removed by filtration and washed with CHCl3
(m, 2 H, CHvCH2), 5.75–5.85 (m, 1 H, CHvCH2), 7.25–7.32 several times. The combined organic solutions were evapor-
(m, 5 H, C6H5); 13C NMR (100 MHz; CDCl3) δ 14.29, 19.89, ated. The residue was purified by column chromatography
22.87, 26.29, 26.31, 27.22, 27.26, 29.13, 29.32, 29.68–29.85, using the gradient technique and CHCl3–Et2O as the eluent to
30.20, 30.29, 32.12, 32.93, 33.96, 37.27, 70.47, 70.70, 70.88, give the methyl-branched diols 20a–c.
71.75, 73.45, 78.05, 114.07, 127.45, 127.54, 128.26, 138.46,
139.17; EI-MS m/z 656 (1%, M − H).
3,3′-O,O-(Dotriacontane-1,32-diyl)bis{2-O-[(10RS)-10-methyl-
hexadecyl]-sn-glycerol} (20a). Following the general procedure,
1-O-Benzyl-2-O-hexadecyl-3-O-[(10RS)-10-methylheptadec-16- 19a (0.66 g) gave 20a (0.49 g, 88%), a white solid. M.p. 49 °C;
en-1-yl]-sn-glycerol (19b). Following the general procedure, [α]D22 +5.5 (c 0.110 g mL−1, CHCl3). C72H146O6 requires C, 78.05;
18b (1.06 g) and 1-bromohexadecane (2.32 g) gave 19b (1.19 g, H, 13.28; found: C, 78.34; H, 13.26%; 1H NMR (400 MHz;
74%), slight yellow oil. [α]D22 +1.1 (c 0.070 g mL−1, CHCl3). CDCl3) δ 0.81 (d, J = 6.4 Hz, 6 H, 2× CHCH3), 0.86 (t, J = 7.0 Hz,
C44H80O3 requires C, 80.42; H, 12.27; found: C, 80.11; H, 6 H, 2× CH2CH3), 1.04–1.35 (m, 106 H, (CH2)28, 2× (CH2)7CH-
1
12.12%; H NMR (400 MHz; CDCl3) δ 0.82 (d, J = 6.4 Hz, 3 H, (CH2)5CH3), 1.50–1.57 (m, 8 H, 4× CH2CH2O), 2.14 (bs, 2 H,
CCH3), 0.87 (t, J = 7.0 Hz, 3 H, CH2CH3), 1.05–1.38 (m, 49 H, 2× OH), 3.39–3.71 (m, 18 H, 8× CH2O, 2× CHO); 13C NMR
This journal is © The Royal Society of Chemistry 2014
Org. Biomol. Chem., 2014, 12, 3649–3662 | 3657